SCHEMBL4247907

SCHEMBL4247907

NCc1cc2cc3ccoc3cc2oc1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 6/20 0.54
CYP3A4 P08684 2/20 0.54
HSD17B10 Q99714 2/20 0.54
ACHE P22303 2/20 0.54
KDM4E B2RXH2 1/20 0.54
CYP2D6 P10635 1/20 0.54
CYP2A6 P11509 1/20 0.54
CYP2C9 P11712 1/20 0.54
NFKB1 P19838 1/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 1/20 0.50
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
PTPN1 P18031 3/20 0.38
MAOB P27338 2/20 0.38
CDK9 P50750 1/20 0.37
DYRK1A Q13627 1/20 0.37
DRD2 P14416 1/20 0.36
GPR55 Q9Y2T6 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936325 0.86 MAOA (0.56) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL6991403 0.84 MAOA (0.54) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL6995029 0.84 MAOA (0.54) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL7003510 0.84 MAOA (0.54) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL5488820 0.79 CYP2A6 (0.59) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL8897227 0.78 MAOA (0.50) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL4235603 0.76 CYP3A4 (0.59) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL3467047 0.76 CYP3A4 (0.59) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL7830030 0.76 CYP2A6 (0.59) MAOACYP3A4HSD17B10ACHEKDM4E
SCHEMBL11392904 0.76 HTT (0.51) MAOACYP3A4HSD17B10ACHEKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4950770-A Psoralens aminomethylation ELDER PHARMACEUTICALS, INC. (US) 1990-08-21 US claimed
US-4542102-A Coupling of nucleic acids to solid support by photochemical methods MOLECULAR DIAGNOSTICS, INC. 1985-09-17 US claimed
EP-2091973-A2 BINARY EPITOPE ANTIBODIES AND B CELL SUPERANTIGEN IMMUNE STIMULANTS Paul, Sudhir (US) 2009-08-26 EP disclosed
US-20090117115-A1 Binary epitope antibodies and B cell superantigen immune stimulants PAUL, SUDHIR, PH.D 2009-05-07 US disclosed
WO-2008133652-A2 BINARY EPITOPE ANTIBODIES AND B CELL SUPERANTIGEN IMMUNE STIMULANTS PAUL SUDHIR (US) 2008-11-06 WO disclosed
US-20070020678-A1 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides AULT-RICHE DANA 2007-01-25 US disclosed
EP-1576126-A3 SYSTEMS FOR CAPTURE AND ANALYSIS OF BIOLOGICAL PARTICLES AND METHODS USING THE SYSTEMS Pointilliste, Inc. (US) 2005-10-26 EP disclosed
EP-1585806-A2 METHODS FOR PRODUCING POLYPEPTIDE-TAGGED COLLECTIONS AND CAPTURE SYSTEMS CONTAINING THE TAGGED POLYPEPTIDES Pointilliste, Inc. (US) 2005-10-19 EP disclosed
EP-1576126-A2 SYSTEMS FOR CAPTURE AND ANALYSIS OF BIOLOGICAL PARTICLES AND METHODS USING THE SYSTEMS Pointilliste, Inc. (US) 2005-09-21 EP disclosed
US-20050042623-A1 Systems for capture and analysis of biological particles and methods using the systems POINTILLISTE, INC. 2005-02-24 US disclosed
US-20040209282-A1 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides POINTILLISTE, INC. 2004-10-21 US disclosed
US-4713326-A AN IMMOBILIZED PROBE; BINDING LIGANDS, DIVALENT RADICALS MOLECULAR DIAGNOSTICS, INC. (US) 1987-12-15 US disclosed
EP-0237833-A2 Solution-phase hybridization assay for detecting polynucleotide sequences MILES INC. (US) 1987-09-23 EP disclosed
EP-0235726-A2 Rapid detection of nucleic acid sequences in a sample by labeling the sample MILES INC. (US) 1987-09-09 EP disclosed
EP-0228075-A2 Eucaryotic genomic dna dot-blot hybridization method MOLECULAR DIAGNOSTICS, INC. (US) 1987-07-08 EP disclosed
EP-0131830-B1 LABELLED NUCLEIC ACID PROBES AND ADDUCTS FOR THEIR PREPARATION MOLECULAR DIAGNOSTICS, INC. (US) 1986-12-10 EP disclosed
EP-0187332-A2 Photochemical method of labelling nucleic acids for detection in hybridization assays MOLECULAR DIAGNOSTICS, INC. (US) 1986-07-16 EP disclosed
US-4542102-A Coupling of nucleic acids to solid support by photochemical methods MOLECULAR DIAGNOSTICS, INC. 1985-09-17 US disclosed
EP-0131830-A1 Labelled nucleic acid probes and adducts for their preparation MOLECULAR DIAGNOSTICS, INC. (US) 1985-01-23 EP disclosed
EP-0130523-A2 Immobilized nucleic acid probe and solid support for nucleic acids MOLECULAR DIAGNOSTICS, INC. (US) 1985-01-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090117115-A1 Binary epitope antibodies and B cell superantigen immune stimulants CD69, CD14, CD4 MAOA 3190/4885CYP3A4 2176/4885HSD17B10 2959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.